{"id":"W4417429226","doi":"10.1111/jdv.70266","title":"Nemolizumab in prurigo nodularis up to 100 weeks: <scp>OLYMPIA LTE</scp> interim analysis","year":2025,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Samsung; LEO Pharma; InflaRx; Horizon Therapeutics; Argenx; Incyte; Kiniksa Pharmaceuticals; Fresenius Medical Care North America; UCB Pharma; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Celgene; Biogen; Sanofi; Celldex Therapeutics; Amgen; Pfizer; Galderma; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Prurigo nodularis; Interim analysis; Interim; MEDLINE; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01419868,0.001543857,0.004040669,0.0006070076,0.0006245816,0.002518371,0.001245685,0.001465385,0.01332846],"category_scores_gemma":[0.009990255,0.0006109125,0.00992588,0.0007390125,0.0005565622,0.00170786,0.001076863,0.004501635,0.002270804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001263839,"about_ca_system_score_gemma":0.002424248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001664019,"about_ca_topic_score_gemma":0.002580184,"domain_scores_codex":[0.9936407,0.003554205,0.0003217388,0.0006121268,0.0007183867,0.001152814],"domain_scores_gemma":[0.9937696,0.002358358,0.001144461,0.001300046,0.0008041219,0.0006233038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8474648,0.003251235,0.01179587,0.002884757,0.0278757,0.0002036053,0.0001191418,0.007139738,0.003098679,0.001042227,0.03136195,0.06376234],"study_design_scores_gemma":[0.5628192,0.1733342,0.1155936,0.002006299,0.05909757,0.0005719605,0.0002582517,0.01376566,0.006353361,0.005498899,0.06047635,0.0002246993],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.763346,0.03089068,0.01533051,0.006464746,0.003341015,0.02050653,0.09103296,0.001637973,0.06744956],"genre_scores_gemma":[0.9010925,0.003320844,0.008502197,0.005199524,0.0008166826,0.02133485,0.0360125,0.0003350301,0.0233859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01419868,"threshold_uncertainty_score":0.07509065,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01500383709292942,"score_gpt":0.3049140783222697,"score_spread":0.2899102412293403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}